Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Antibody R&D Service

Antibody R&D Service

Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D.

Antibody R&D Service

Medicilon provides antibody drugs discovery, CMC research (API + formulation), pharmacodynamics research, PK study, safety evaluation and other services. As of April 2024, Medicilon has successfully assisted clients on the IND approval of 34 antibody drugs (8 approved by FDA and NMPA, 3 approved by NMPA and TGA, 1 approved by FDA, NMPA, and TGA) and has multiple antibody projects on going.
Download
Antibodies Discovery
In Vitro Study of Antibodies
CMC Research of Antibodies
Pharmacology Evaluation of Antibodies
Pharmacokinetic (PK) Studies of Antibodies
Safety Evaluation of Antibodies
Medicilon Assisted Projects
Relevant laboratories
prev page next page
  • Pharmacokinetics laboratory
  • Immunoassay Platform
  • isotope
  • LC-MS-MS
  • High activity laboratory
Return